Mali vs Vanuatu: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Mali
1.8%
in 2024
Vanuatu
1.8%
in 2024
Mali rank
14th
Vanuatu rank
14th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Mali
- Vanuatu
How they compare
Mali currently reports 1.8% against 1.8% in Vanuatu, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Vanuatu ahead.
Mali ranks 14th and Vanuatu ranks 14th of 215 countries.
Mali has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mali | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.1% | 1.6% | 0.4% | Mali |
| 2020s | 2.1% | 1.7% | 0.4% | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Mali or Vanuatu?
- Mali, at 1.8% against 1.8% in Vanuatu as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Mali and Vanuatu?
- 0.0%, with Mali ahead.
- How many years of comparable data are there for Mali and Vanuatu?
- 10 years are reported by both, from 2015 to 2024.
- How do Mali and Vanuatu rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Mali ranks 14th and Vanuatu ranks 14th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.